JBM (Healthcare) (HKSE:02161) LT-Debt-to-Total-Asset : 0.01 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is JBM (Healthcare) LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. JBM (Healthcare)'s long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.01.

JBM (Healthcare)'s long-term debt to total assets ratio declined from Sep. 2023 (0.04) to Sep. 2024 (0.01). It may suggest that JBM (Healthcare) is progressively becoming less dependent on debt to grow their business.

JBM (Healthcare) LT-Debt-to-Total-Asset Historical Data

The historical data trend for JBM (Healthcare)'s LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JBM (Healthcare) LT-Debt-to-Total-Asset Chart

JBM (Healthcare) Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.33

0.14

0.10

0.06

0.04

JBM (Healthcare) Semi-Annual Data
	Mar18	Mar19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial							0.09	0.06	0.04	0.04	0.01

JBM (Healthcare) LT-Debt-to-Total-Asset Calculation

JBM (Healthcare)'s Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	50.899	/	1388.697
	=	0.04

JBM (Healthcare)'s Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	6.655	/	1409.493
	=	0.00

JBM (Healthcare) (HKSE:02161) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

JBM (Healthcare) LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of JBM (Healthcare)'s LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

JBM (Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JBM (Healthcare) Ltd (HKSE:02161) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

108 Wai Yip Street, Units 808-811, 8 floor, C-Bons International Centre, Kwun Tong, Kowloon, Hong Kong, HKG

Website

https://www.jbmhealthcare.com.hk

JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.

Executives

Ubs Trustees (b.v.i.) Limited
Kingshill Development Group Inc
Sum Kwong Yip, Derek
Queenshill Development Limited
Lincoln's Hill Development Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si
New Heritage Healthcare Limited	2101 Beneficial owner
Gavett Limited	2201 Interest of corporation controlled by you
United Islands Group Limited	2201 Interest of corporation controlled by you
Fortstar Limited	2201 Interest of corporation controlled by you
Tao Richard	2201 Interest of corporation controlled by you
Hon Hing Tong Patricia	2202 Interest of your spouse
Tao Paul	2201 Interest of corporation controlled by you
Choi Siu Ping	2202 Interest of your spouse
Longjin Investments Limited	2101 Beneficial owner

JBM (Healthcare) Headlines

No Headlines